Standardized Antihypertensive Treatment Protocol

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 24, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hypertension
Interventions
DRUG

Usual Care

The doctor prescribes medication for patients and follow-up every 3 months

DRUG

Standard Medical Therapy

The standard treatment group was followed up monthly, Amlodipine 5 mg is preferred for selected patients, and amlodipine 5 mg + irbesartan 150mg is used for those who do not meet blood pressure targets after 4 weeks treatment, amlodipine 10mg + irbesartan 300mg is used for those who do not meet blood pressure targets after one month, for those whose blood pressure is still not up to standard after 4 weeks will be treated with amlodipine 10mg + irbesartan 300mg + hydrochlorothiazide 12.5mg.

Trial Locations (1)

200025

Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
collaborator

Vital Strategies

OTHER

lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT06790927 - Standardized Antihypertensive Treatment Protocol | Biotech Hunter | Biotech Hunter